Sudden confusion, seizures, personality changes, memory loss, and shaky movements can point doctors toward many possible diagnoses. Stroke, infection, medication side effects, metabolic problems, epilepsy, and autoimmune encephalitis may all enter the conversation. Far down the listusually wearing a disguise and carrying no convenient instruction manualis a rare condition called Hashimoto encephalopathy.
Hashimoto encephalopathy is an uncommon syndrome involving impaired brain function and elevated thyroid-related antibodies. It is also known as steroid-responsive encephalopathy associated with autoimmune thyroiditis, or SREAT. Despite the name, it is not simply ordinary Hashimoto thyroiditis spreading from the thyroid to the brain. The relationship between the two conditions remains uncertain, and experts continue to debate how Hashimoto encephalopathy should be defined.
Sources consulted:
What Is Hashimoto Encephalopathy?
Encephalopathy is a broad medical term meaning that the brain is not functioning normally. It can affect awareness, thinking, memory, behavior, movement, speech, or consciousness. Many illnesses can cause encephalopathy, including severe infections, liver or kidney failure, toxins, vitamin deficiencies, endocrine disorders, strokes, seizures, and immune-system diseases.
Hashimoto encephalopathy is generally described as an apparently immune-mediated encephalopathy occurring in a person with elevated antibodies against thyroid proteins, most commonly thyroid peroxidase antibodies or thyroglobulin antibodies. Symptoms may improve after immunotherapy, particularly corticosteroids, although steroid response is not universal and cannot prove the diagnosis by itself.
The condition has been reported in children, adults, and older people, but published cases occur more frequently in women. One often-cited estimate suggests a prevalence of approximately 2.1 cases per 100,000 adults. However, the true frequency is unknown because diagnostic definitions differ, mild cases may be missed, and other illnesses may sometimes be mislabeled as Hashimoto encephalopathy.
Sources consulted:
Is It the Same as Hashimoto Thyroiditis?
No. Hashimoto thyroiditis is a common autoimmune disorder in which the immune system damages the thyroid gland. Over time, that damage can reduce thyroid hormone production and cause hypothyroidism. Typical symptoms include fatigue, cold intolerance, constipation, dry skin, weight changes, muscle aches, and slowed thinking.
Hashimoto encephalopathy is primarily a neurologic syndrome. A person may have normal thyroid hormone levels, mild hypothyroidism, previously diagnosed Hashimoto thyroiditis, or no known thyroid disease before neurological symptoms begin. Correcting low thyroid hormone is important, but levothyroxine alone does not treat suspected immune-mediated brain inflammation.
The shared feature is the presence of thyroid autoantibodies. Unfortunately, these antibodies are not exclusive to Hashimoto encephalopathy. They are common in autoimmune thyroid disease and may also be detected in people who have no neurological illness. Think of them as a clue on the detective board, not a signed confession.
Sources consulted:
Hashimoto Encephalopathy Symptoms
The symptoms of Hashimoto encephalopathy vary dramatically. They may appear over days or weeks, fluctuate over time, or progress gradually. Some people experience distinct attacks followed by partial recovery, while others develop steadily worsening cognitive and behavioral changes.
Changes in Thinking and Awareness
Common cognitive and consciousness-related symptoms may include:
- Confusion or disorientation
- Short-term memory problems
- Difficulty concentrating or following conversations
- Unusual sleepiness or reduced alertness
- Rapidly worsening cognitive function
- Episodes of unresponsiveness
- Severe cases involving stupor or coma
These changes are usually more severe than the mild “brain fog” sometimes associated with poor sleep, stress, depression, or hypothyroidism. Someone with encephalopathy may become lost in a familiar place, fail to recognize relatives, speak incoherently, or be unable to perform routine tasks.
Psychiatric and Behavioral Symptoms
Hashimoto encephalopathy can sometimes resemble a primary psychiatric disorder. Reported symptoms include agitation, emotional instability, paranoia, hallucinations, delusions, depression, and major personality changes. In some cases, psychiatric symptoms appear before obvious neurological abnormalities, complicating the diagnostic process.
Seizures
Seizures are among the most frequently reported neurological features. They may be focal, affecting one region of the brain, or generalized. Some people develop repeated seizures or status epilepticus, a prolonged or recurring seizure emergency requiring immediate hospital treatment.
Movement and Coordination Problems
Possible movement-related symptoms include tremor, muscle jerks known as myoclonus, poor balance, an unsteady gait, clumsiness, muscle stiffness, and impaired coordination. Speech may become slow, slurred, or temporarily difficult to produce.
Stroke-Like Episodes
Some patients experience temporary weakness, numbness, speech difficulty, visual symptoms, or other focal neurological deficits that resemble a stroke. A real stroke must be ruled out urgently. Nobody should stay home debating rare autoimmune conditions while one side of the body has suddenly stopped cooperating.
Other Possible Symptoms
Headaches, sleep disturbances, fatigue, sensory changes, temporary language loss, abnormal eye movements, and episodes resembling migraine have also been reported. Because no single symptom defines the disorder, diagnosis depends on the overall clinical pattern and extensive testing.
Sources consulted:
What Causes Hashimoto Encephalopathy?
The exact cause remains unknown. Most researchers suspect an immune-mediated process, but the precise target and mechanism have not been established. Several explanations have been proposed, including inflammation of small blood vessels, immune complexes, altered blood-brain barrier function, and antibodies reacting with proteins found in nervous-system tissue.
Thyroid antibodies themselves may not directly attack the brain. Antibody levels do not consistently match symptom severity, and reducing antibody concentrations does not always produce neurological improvement. Many specialists therefore regard thyroid antibodies as markers of autoimmune susceptibility rather than proven disease-causing agents.
This uncertainty is one reason some clinicians prefer the name SREAT. Even that term has limitations, however, because not every well-documented patient responds completely to steroids. Medical naming can occasionally resemble reorganizing a sock drawer during a thunderstorm: useful, but it does not solve the storm.
Sources consulted:
How Is Hashimoto Encephalopathy Diagnosed?
There is no single blood test, scan, biopsy, or examination that confirms Hashimoto encephalopathy. It is a diagnosis of exclusion, meaning doctors must first investigate more common and better-defined causes of brain dysfunction.
A multidisciplinary team may include neurologists, endocrinologists, rheumatologists, infectious disease specialists, psychiatrists, and intensive-care physicians. The exact evaluation depends on the patient’s symptoms, age, medical history, medications, and speed of decline.
Medical History and Neurological Examination
Doctors ask when symptoms began, whether they fluctuate, whether seizures occurred, and whether the person has thyroid disease, autoimmune conditions, recent infections, cancer, toxin exposure, substance use, or new medications. Family observations can be especially valuable because people with encephalopathy may not recognize their own behavioral or memory changes.
Blood Tests
Testing commonly includes thyroid-stimulating hormone, free thyroxine, thyroid peroxidase antibodies, and thyroglobulin antibodies. Doctors may also check blood counts, electrolytes, blood sugar, liver and kidney function, inflammatory markers, vitamin levels, toxic exposures, infections, and indicators of other autoimmune diseases.
Elevated thyroid antibodies may support consideration of Hashimoto encephalopathy, but they are not sufficient for diagnosis. A Mayo Clinic review of people referred with suspected Hashimoto encephalopathy found that many ultimately had nonimmune explanations for their symptoms, highlighting the risk of relying too heavily on antibody results.
Sources consulted:
Brain MRI
Magnetic resonance imaging may be normal. When abnormalities are present, they are often nonspecific, such as scattered white-matter changes, swelling, atrophy, or areas of altered signal. MRI remains essential because it can reveal strokes, tumors, demyelinating disease, infection, and other structural causes.
Electroencephalogram
An electroencephalogram, or EEG, records electrical brain activity. Diffuse slowing is commonly reported in encephalopathy, but it does not identify a specific cause. EEG testing can also detect seizures that produce confusion without obvious convulsions.
Lumbar Puncture
Cerebrospinal fluid obtained through a lumbar puncture may show elevated protein or mild inflammation, although normal results are possible. Fluid testing helps rule out viral or bacterial infection, cancer, multiple sclerosis-related disorders, and recognized forms of autoimmune encephalitis.
Autoimmune Encephalitis Testing
Serum and cerebrospinal fluid may be tested for antibodies associated with established autoimmune encephalitis syndromes. Depending on the clinical picture, these can include antibodies involving NMDA receptors, LGI1, CASPR2, GABA receptors, AMPA receptors, and other neuronal targets.
Testing both blood and cerebrospinal fluid is often useful because some antibodies are more reliably detected in one specimen than the other. Results must always be interpreted alongside symptoms, MRI findings, EEG results, and the exclusion of infections and metabolic causes.
Sources consulted:
Conditions That Can Resemble Hashimoto Encephalopathy
The differential diagnosis is broad and may include:
- Infectious encephalitis or meningitis
- Autoimmune encephalitis involving neuronal antibodies
- Stroke, brain hemorrhage, or cerebral vasculitis
- Medication toxicity or substance exposure
- Liver, kidney, electrolyte, glucose, or endocrine disorders
- Severe hypothyroidism or myxedema coma
- Vitamin B1 or vitamin B12 deficiency
- Epilepsy and nonconvulsive status epilepticus
- Brain tumors or paraneoplastic syndromes
- Rapidly progressive neurodegenerative diseases
- Primary psychiatric disorders
Several of these conditions require treatments very different from immunosuppression. Giving high-dose steroids before appropriately excluding infection, for example, may worsen an untreated infection. Careful evaluation is not bureaucratic stalling; it is part of safe treatment.
Sources consulted:
Hashimoto Encephalopathy Treatment
Corticosteroids
Corticosteroids are the most commonly used first-line treatment when doctors strongly suspect an immune-mediated encephalopathy. A hospitalized patient with severe symptoms may receive intravenous methylprednisolone followed by oral prednisone. The dose, treatment duration, and tapering schedule vary considerably because randomized clinical trials and universally accepted guidelines are lacking.
Some patients improve within days, while others recover gradually over weeks or months. Older reports described very high response rates, but newer analyses have questioned those figures and emphasized that steroid response is less consistent than the traditional name SREAT suggests.
High-dose or prolonged steroid therapy can cause elevated blood sugar, infection risk, insomnia, mood changes, high blood pressure, bone loss, muscle weakness, stomach irritation, and other complications. Treatment requires medical supervision and should not be stopped abruptly unless clinicians provide specific instructions.
Other Immunotherapies
When corticosteroids are ineffective, poorly tolerated, or followed by repeated relapses, specialists may consider intravenous immunoglobulin or plasma exchange. Steroid-sparing medicines reported in difficult cases include azathioprine, mycophenolate mofetil, rituximab, methotrexate, and cyclophosphamide.
Evidence for these treatments is based mainly on case reports, small case series, and retrospective reviews. The choice depends on symptom severity, previous response, other health conditions, medication risks, and whether the diagnosis remains convincing after reassessment.
Sources consulted:
Managing Seizures and Other Symptoms
Antiseizure medication may be needed during the acute illness. Patients may also require physical therapy, occupational therapy, speech therapy, psychiatric support, sleep management, and temporary assistance with daily activities. Severe cases may require intensive-care monitoring, respiratory support, or treatment for complications of prolonged seizures.
Treating Thyroid Dysfunction
People with hypothyroidism generally receive levothyroxine to restore appropriate thyroid hormone levels. This can improve symptoms caused by hypothyroidism, but thyroid replacement and immunotherapy serve different purposes. Normalizing thyroid tests does not necessarily end the neurological illness.
Sources consulted:
Recovery, Relapse, and Long-Term Outlook
Many reported patients improve substantially after appropriate treatment, particularly when severe symptoms are recognized early. Memory, speech, behavior, balance, and seizure control may continue improving after the acute inflammatory episode has settled.
Recovery is not always immediate or complete. Some people experience residual memory problems, fatigue, mood changes, movement difficulties, or reduced ability to work independently. Relapses can occur during steroid tapering or months to years after treatment, so follow-up with a neurologist is important.
Doctors may track symptoms, neurological examination findings, EEG changes, medication side effects, thyroid function, and rehabilitation progress. Thyroid antibody levels may remain elevated even when the person feels better, so treatment decisions should not be based on antibody numbers alone.
Sources consulted:
Experiences Related to Hashimoto Encephalopathy
The following scenarios are fictional composites based on patterns described in clinical literature. They are not individual patient histories and should not be used for self-diagnosis.
Experience 1: When “Stress” Does Not Explain Everything
Imagine a 46-year-old office manager who begins forgetting appointments, repeating questions, and struggling to operate software she has used for years. At first, everyone blames stress. She has been sleeping poorly, juggling deadlines, and caring for an elderly parent. Stress seems like a perfectly tidy explanationuntil the symptoms stop being tidy.
Over the next two weeks, she becomes suspicious that coworkers are discussing her, hears a voice when nobody is nearby, and briefly fails to recognize the route home. Her family takes her to an emergency department. Brain imaging shows no major stroke or tumor. Infection testing is negative, but an EEG reveals generalized slowing. Blood tests identify high thyroid peroxidase antibodies even though her thyroid hormone levels are close to normal.
The antibodies do not automatically establish Hashimoto encephalopathy. Her medical team checks cerebrospinal fluid, screens for neuronal antibodies, reviews medications, evaluates metabolic causes, and consults neurology and psychiatry. Only after more likely explanations are excluded does immune treatment enter the plan. Her recovery is gradual rather than cinematic: hallucinations improve first, concentration returns later, and fatigue lingers for months.
Experience 2: A Seizure Changes the Investigation
Consider a 32-year-old teacher with a history of Hashimoto thyroiditis who develops headaches, hand tremors, and brief episodes in which he stops responding. Because his thyroid tests are stable, he assumes the symptoms are unrelated. One morning, he has a generalized seizure.
Hospital testing reveals no infection, intoxicant, severe electrolyte abnormality, or structural brain lesion. EEG monitoring detects additional focal seizures. Elevated thyroid antibodies attract attention, but the neurologist explains that many people with Hashimoto thyroiditis have those antibodies without encephalopathy. The entire clinical picturenot one dramatic laboratory resultmust guide the diagnosis.
He receives antiseizure treatment while doctors investigate autoimmune and infectious causes. Immunotherapy is eventually started because the evidence supports inflammatory encephalopathy. Seizures come under control, but returning to teaching requires patience, reduced hours, and speech-language therapy for word-finding problems. Recovery looks less like flipping a switch and more like slowly turning up a dimmer.
Experience 3: The Frustration of an Uncertain Diagnosis
A 67-year-old retiree develops worsening balance, confusion, and sudden episodes of slurred speech. One physician suspects mini-strokes. Another considers rapidly progressive dementia. Thyroid antibodies are positive, and the family discovers Hashimoto encephalopathy online. They understandably want treatment immediately.
The neurologist remains cautious because the MRI shows abnormalities that could have several causes, and the symptoms do not clearly follow a typical autoimmune pattern. Additional testing reveals a different neurological disease. This outcome is emotionally difficult, but it demonstrates why Hashimoto encephalopathy cannot be diagnosed from thyroid antibodies plus unexplained symptoms.
For families navigating a similar evaluation, keeping a dated symptom log may help. Record seizures, confusion, sleep changes, medication adjustments, fevers, speech problems, falls, and changes in daily functioning. Videos of unusual movements may also assist clinicians. Most importantly, seek urgent care for sudden neurological changes rather than waiting for a specialist appointment or attempting to match symptoms to an online checklist.
Conclusion
Hashimoto encephalopathy is a rare and controversial neurological syndrome associated with thyroid autoantibodies, altered brain function, and possible responsiveness to immune treatment. Symptoms can include confusion, seizures, hallucinations, memory decline, tremor, poor coordination, and stroke-like episodes.
Because thyroid antibodies are relatively common and no definitive test exists, diagnosis requires a thorough search for infections, metabolic disorders, epilepsy, strokes, tumors, established autoimmune encephalitis syndromes, medication effects, and other causes. Corticosteroids remain the most frequently used treatment, while intravenous immunoglobulin, plasma exchange, and additional immunosuppressive drugs may be considered in selected cases.
The most useful takeaway is not that every person with Hashimoto thyroiditis and brain fog has encephalopathy. Most do not. The important lesson is that rapidly developing confusion, psychiatric changes, seizures, or neurological deficits deserve prompt medical evaluationand that potentially treatable immune-mediated conditions should remain on the diagnostic radar when more common explanations do not fit.
